Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.26, read 2026-10-23
Ethical does not pass the values gate
Price37.61 USD
Fair value48.12
Ethical score70.0/100
Our investment reviews on this name
2026-10-24Read Distribution35.29+6.6% to today Markup gives way to Distribution after a 66% rise in 16 weeks
2026-07-02Read Markup21.23+77.2% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Five9, Inc. holds its Distribution at $37.61. Consolidating, no directional conviction, held for 22 days.
As held on the ledger · 2026-10-23
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 22 days
Price at the screen
$37.61
Valuation
51.14 trailing · 9.19 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.54
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
44.98%
Below 33%
Interest-bearing debt is 45.0% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
25.97%
Below 33%
Cash held in interest-bearing accounts and securities is 26.0% of assets, under the one-third limit.
Pass
Receivables
19.27%
Below 49%
Money owed to the company is 19.3% of assets, under the 49% limit.
Pass
Revenue purity
2.63%
Below 5%
Only 2.6% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Five9,'s business is in a permissible area, but its interest-bearing debt is about 45% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when FIVN's ethical verdict changes
Today FIVN does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 36.4% margin of safety to the base estimate.
Third-party analyst targets: 20 covering, consensus Buy. The average target sits +2% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Contact centre cloud that investors simply ignore
Picture the moment a frustrated caller reaches a support line. Five9 powers that cloud platform for many firms, yet the numbers tell a flat story. Revenue grows at just 9% while profit margins sit at 5% and return on equity reaches only 8%. Our fair value sits 22% above the current price, but the opportunity rating stays at none because the business shows no real acceleration or durable edge.
Analysts set a median target exactly at today's level of 25.58 dollars and assign no consensus rating. The forward multiple of 6.8 times looks cheap until you weigh the thin margins and unknown moat against peers that deliver faster expansion. The ethical screen clears, yet that alone does not create an investment case when growth and returns remain so modest.
Low profitability leaves little room for error if competition intensifies or enterprise budgets tighten. Without visible scale advantages the valuation discount may simply reflect those limits rather than an overlooked bargain. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
FIVN trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 38% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (21 analysts) rates it none, with a mean price target of $28.
2026-10-17Markup$35.41+9.1%Entry 7
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 9.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (21 analysts) rates it none, with a mean price target of $28.
2026-10-02Markup$32.47-6.1%Entry 6
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (21 analysts) rates it none, with a mean price target of $28.
2026-08-29Markup$34.57+35.1%Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 35.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (21 analysts) rates it none, with a mean price target of $28.
2026-07-28Markup$25.58+20.5%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 20.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (21 analysts) rates it none, with a mean price target of $28.
2026-07-18Markup$21.23+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (21 analysts) rates it none, with a mean price target of $28.
2026-07-03Markup$21.23+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Markup$21.23Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
